New Delhi, May 26, 2011: One the fastest growing, pharmaceutical companies Core Gestra Pvt. Ltd bagged the Arch of Excellence in Pharma Award 2011. The award was presented at a glitzy award ceremony organized by All India Achievers Conference to honor corporate and individual achievements in nation building. The presentation ceremony was attended by top-notch corporate big-wigs, leading film stars as well well-known personalities from different fields.
New Delhi, May 26, 2011: One the fastest growing, pharmaceutical companies Core Gestra Pvt. Ltd bagged the Arch of Excellence in Pharma Award 2011. The award was presented at a glitzy award ceremony organized by All India Achievers Conference to honor corporate and individual achievements in nation building. The presentation ceremony was attended by top-notch corporate big-wigs, leading film stars as well well-known personalities from different fields.
At the same award ceremony Core Group Managing Director, Sunil Kumar was awarded Promising Businessman of the Year Award in the individual category.
Speaking to the media after the award, Sunil Kumar said, “This award is an endorsement of our efforts to create brands people love. Core Group’s unending quest is to provide specialty products and innovative solutions – that can satisfy unmet medical needs and contribute to a better and healthier world.”
CORE GROUP is known for developing and marketing one of the lowest cost, high quality, safe, effective and proven medicines for a wide variety of seasons and reasons. The aim is to help people live longer, live better.
Core Group’s varied product basket includes prescription Antibiotics & Life Saving medicines, Analgesic & Pain Killers, Gynecological, Pediatric, Gastrointestinal, Orthopedics, Injectibles and expectorants. The gynecological range may further be sub-divided into Calcium Supplements, Iron Supplements, Multi-vitamin, Multi-mineral and products for anti-nauseant / antiemetic management of nausea and vomiting during Pregnancy (NVP). To add further punch to its gastrointestinal range the company is now launching a new product called Hitoliv (L-ornithine L-aspartate) –a prescription drug for severe liver impairment. L-Ornithine-L-Aspartate is useful in the treatment of high ammonia levels or when a patient’s liver function is extremely poor. L-O-L-A is very effective for end-stage cirrhotic patients.
All these products are manufactured as per US Food and Drug Administration (USFDA) and World Health Organization's Good Manufacturing Practice (WHO GMP) Regulations. Sometimes also referred to as cGMPs or Current Good Manufacturing Practices these are a set of regulations, codes, and guidelines for the manufacture of drugs, medical devices, diagnostic aids and Active Pharmaceutical Ingredients (APIs) to ensure ensures a drug with zero defects.